Skip to main content

Advertisement

SpringerLink
Log in

Testosterone supplementation in the patient with erectile dysfunction

  • Published:
Current Sexual Health Reports Aims and scope Submit manuscript

Abstract

Erectile dysfunction and hypogonadism are becoming two of the most frequently diagnosed sexual dysfunctions in men. They are often diagnosed together, and more men than before are being treated with both testosterone and phosphodiesterase type 5 inhibitors. Testosterone supplementation is a safe and effective treatment for men with hypogonadism, especially if they have erectile dysfunction as a result of hypogonadism. Testosterone supplementation for men with hypogonadism should be reserved for those with low serum testosterone accompanying the symptoms of hypogonadism, including erectile dysfunction. A careful baseline monitoring of prostate-specific antigen (PSA), a complete blood count, and an initial serum testosterone level are essential for initiation of testosterone supplementation. Clinicians must carefully monitor treatment, including both PSA monitoring and a complete blood count at regular intervals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Steidle C, Schwartz S, Jacoby K, et al.: AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Enocrinol Metab 2003, 88:2673–2681.

    Article  CAS  Google Scholar 

  2. Lee KK, Berman N, Alexander GM, et al.: A simple self-report diary for assessing psychosexual function in hypogonadal men. J Androl 2003, 24:688–698.

    PubMed  Google Scholar 

  3. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002, 57:M76-M99.

    PubMed  Google Scholar 

  4. McNicholas TA, Dean JD, Mulder H, et al.: A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003, 91:69–74.

    Article  PubMed  CAS  Google Scholar 

  5. Schrader S, Mills A, Scheperle M, Block JE: Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males. Clinical Cornerstone 2005, 7 (Suppl 4):S26-S31.

    Article  PubMed  Google Scholar 

  6. Carnegie C: Diagnosis of hypogonadism: clinical assessments and laboratory tests. Rev Urol 2004, 6 (Suppl 6):S3-S8.

    PubMed  Google Scholar 

  7. Aschoff S: Helping Men Age Gracefully Series: PULSE. St. Petersburg Times. January 27, 2004:E3

  8. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004, 172:658–663.

    Article  PubMed  CAS  Google Scholar 

  9. Dean J, Carnegie C, Rodzvilla J, Smith T: Long-term effects of Testim 1% testosterone gel in hypogonadal men. Rev Urol 2004, 6 (Suppl 6):S22-S29.

    PubMed  Google Scholar 

  10. Loizides E, Swierzewski M, O’Neill C, et al.: Early response time in sexual activity and mood following testosterone gel replacement in hypogonadal males from the Testim start study. Rev Urol 2004, 6 (Suppl 6):S16-S21. This article characterizes testosterone function with regard to sexual activity and its improvement.

    PubMed  Google Scholar 

  11. Wang C, Swerdloff RS, Iranmanesh A, et al.: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Enocrinol Metab 2002, 85:2839–2853.

    Article  Google Scholar 

  12. Guay AT, Velasquez E, Perez JB: Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract 1999, 5:314–321.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northeast Indiana Urology, PC, 2512 East Dupont Road, Suite 100, 46825, Fort Wayne, IN, USA

    Christopher P. Steidle MD

Authors
  1. Christopher P. Steidle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher P. Steidle MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steidle, C.P. Testosterone supplementation in the patient with erectile dysfunction. Curr sex health rep 3, 127–130 (2006). https://doi.org/10.1007/s11930-006-0015-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11930-006-0015-5

Keywords

Search

Navigation